Company Stock to Trade on Nasdaq Under the Symbol: ANSV SOUTH SAN FRANCISCO, Calif., June 21 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today announced that it has changed its name...
SOUTH SAN FRANCISCO, Calif., June 20 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today announced that it has received a commitment for up to $30 million in common stock equity...
SOUTH SAN FRANCISCO, Calif., June 14 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today reported positive, top-line clinical data from a Phase 2 clinical trial in total knee...
SOUTH SAN FRANCISCO, Calif., June 7 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today announced that John P. McLaughlin, the company's chief executive officer, will present at the...
SOUTH SAN FRANCISCO, Calif., June 6 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today announced the appointment of K. Peony Yu, M.D., as vice president of clinical research and...
SOUTH SAN FRANCISCO, Calif., May 30 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today announced the appointment of Susan Kramer, Dr.P.H. as vice president of preclinical...
SOUTH SAN FRANCISCO, Calif., May 22 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) will host a webcast conference call on Wednesday, May 24, 2006 at 4:30 p.m. Eastern Time. Members of...
SOUTH SAN FRANCISCO, Calif., May 18 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today announced that positive safety and efficacy data from one of two pivotal Phase 3 studies of its...
Management Will Host Conference Call at 4:30 p.m. EDT SOUTH SAN FRANCISCO, Calif., May 4 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK) today reported financial results for the first...
Additional Data in Morton's Neuroma Also Presented; Abstracts #5659 and #5663 at American Pain Society Meeting SAN ANTONIO and SOUTH SAN FRANCISCO, Calif., May 4 /PRNewswire-FirstCall/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.